MedTrace Logo

Treatment of Depression in Parkinson's Disease

NCT01416818 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-08-15

No results posted yet for this study

Summary

The goal of this study is to evaluate the efficacy of Traditional Chinese Medicine-"Xiaoyao Pill" (Herb extracts)on depression, compared to placebo and "Bupleurum+Ginkgo" in patients with Parkinson's disease.

Conditions

  • Depression in Parkinson's Disease

Interventions

DRUG

Xiaoyao Pill

herb extracts,were received two times a day for 12 weeks without dose changing.

DRUG

Bupleurum+Ginkgo

herb extracts, were received two times a day for 12 weeks without dose changing.

DRUG

placebo

The placebo looked like herb extracts and were also received two times a day for 12 weeks without dose changing.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Piu Chan, MD. PhD. · Xuanwu Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2011-10-31
Completion
2011-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416818 on ClinicalTrials.gov